Optimizing Dual Antiplatelet Therapy in the Perioperative Period for Spine Surgery After Recent Percutaneous Coronary Intervention: A Comprehensive Review, Synthesis, and Catalyst for Protocol Formulation

World Neurosurg. 2024 May:185:267-278. doi: 10.1016/j.wneu.2024.03.005. Epub 2024 Mar 7.

Abstract

The increased incidence of spine surgery within the past decade has highlighted the importance of robust perioperative management to improve patient outcomes overall. Coronary artery disease is a common medical comorbidity present in the population of individuals who receive surgery for spinal pathology that is often treated with dual antiplatelet therapy (DAPT) after percutaneous coronary intervention. Discontinuation of DAPT before surgical intervention is typically indicated; however, contradictory evidence exists in the literature regarding the timing of DAPT use and discontinuation in the perioperative period. We review the most recent cardiac and spine literature on the intricacies of percutaneous coronary intervention and its associated risks in the postoperative period. We further propose protocols for DAPT use after both elective and urgent spine surgery to optimize perioperative care.

Keywords: Dual-antiplatelet therapy; Percutaneous coronary intervention; Spine surgery.

Publication types

  • Review

MeSH terms

  • Coronary Artery Disease / surgery
  • Dual Anti-Platelet Therapy / methods
  • Humans
  • Percutaneous Coronary Intervention* / methods
  • Perioperative Care* / methods
  • Perioperative Period
  • Platelet Aggregation Inhibitors* / administration & dosage
  • Platelet Aggregation Inhibitors* / therapeutic use
  • Spine / surgery

Substances

  • Platelet Aggregation Inhibitors